IRIS Accounts Production v25.4.12.37 SC230837 Board of Directors 1.1.25 31.12.25 31.12.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh SC230837 2024-12-31 SC230837 2025-12-31 SC230837 2025-01-01 2025-12-31 SC230837 2023-12-31 SC230837 2024-01-01 2024-12-31 SC230837 2024-12-31 SC230837 ns15:Scotland 2025-01-01 2025-12-31 SC230837 ns14:PoundSterling 2025-01-01 2025-12-31 SC230837 ns10:Director1 2025-01-01 2025-12-31 SC230837 ns10:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 SC230837 ns10:SmallEntities 2025-01-01 2025-12-31 SC230837 ns10:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 SC230837 ns10:SmallCompaniesRegimeForDirectorsReport 2025-01-01 2025-12-31 SC230837 ns10:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 SC230837 ns10:FullAccounts 2025-01-01 2025-12-31 SC230837 ns5:CurrentFinancialInstruments 2025-12-31 SC230837 ns5:CurrentFinancialInstruments 2024-12-31 SC230837 ns5:Non-currentFinancialInstruments 2025-12-31 SC230837 ns5:Non-currentFinancialInstruments 2024-12-31 SC230837 ns5:ShareCapital 2025-12-31 SC230837 ns5:ShareCapital 2024-12-31 SC230837 ns5:SharePremium 2025-12-31 SC230837 ns5:SharePremium 2024-12-31 SC230837 ns5:CapitalRedemptionReserve 2025-12-31 SC230837 ns5:CapitalRedemptionReserve 2024-12-31 SC230837 ns5:RetainedEarningsAccumulatedLosses 2025-12-31 SC230837 ns5:RetainedEarningsAccumulatedLosses 2024-12-31 SC230837 ns5:LandBuildings 2025-01-01 2025-12-31 SC230837 ns5:PlantMachinery 2025-01-01 2025-12-31 SC230837 ns5:LandBuildings 2025-12-31 SC230837 ns5:PlantMachinery 2025-12-31 SC230837 ns5:LandBuildings 2024-12-31 SC230837 ns5:PlantMachinery 2024-12-31 SC230837 ns5:LandBuildings 2024-12-31 SC230837 ns5:PlantMachinery 2024-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2024-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee 2024-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2025-01-01 2025-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee 2025-01-01 2025-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2025-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee 2025-12-31 SC230837 ns5:LeasedAssetsHeldAsLessee 2024-12-31 SC230837 ns5:CostValuation 2024-12-31 SC230837 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-12-31 SC230837 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-12-31 SC230837 ns5:Secured 2025-12-31 SC230837 ns5:Secured 2024-12-31

REGISTERED NUMBER: SC230837 (Scotland)

Unaudited Financial Statements for the Year Ended 31 December 2025

for

Impact Laboratories Limited

Impact Laboratories Limited (Registered number: SC230837)

Contents of the Financial Statements

for the Year Ended 31 December 2025

Page |

Balance Sheet | 1 |

Notes to the Financial Statements | 3 |

Impact Laboratories Limited (Registered number: SC230837)

Balance Sheet

31 December 2025

| 31.12.25 |  | 31.12.24

| Notes | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 3,869,346 |  | 4,123,847 |  |

Investments | 5 | 108,833 |  | 108,833 |  |

3,978,179 |  | 4,232,680 |  |

CURRENT ASSETS

Debtors | 6 | 905,417 |  | 1,178,744 |  |

Cash at bank and in hand | 69,223 |  | 131,650 |  |

974,640 |  | 1,310,394 |  |

CREDITORS

Amounts falling due within one year | 7 | (457,309 | ) | (641,879 | ) |

NET CURRENT ASSETS | 517,331 |  | 668,515 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 4,495,510 |  | 4,901,195 |  |

CREDITORS

Amounts falling due after more than one year | 8 | (1,267,443 | ) | (1,542,017 | ) |

PROVISIONS FOR LIABILITIES | (97,583 | ) | (134,475 | ) |

NET ASSETS | 3,130,484 |  | 3,224,703 |  |

CAPITAL AND RESERVES

Called up share capital | 43,222 |  | 43,220 |  |

Share premium | 1,496 |  | 1,496 |  |

Capital redemption reserve | 27,350 |  | 27,350 |  |

Retained earnings | 3,058,416 |  | 3,152,637 |  |

SHAREHOLDERS' FUNDS | 3,130,484 |  | 3,224,703 |  |

Impact Laboratories Limited (Registered number: SC230837)

Balance Sheet - continued

31 December 2025

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 February 2026 and were signed on its behalf by:

Mr K V Ross - Director

Impact Laboratories Limited (Registered number: SC230837)

Notes to the Financial Statements

for the Year Ended 31 December 2025

1. | STATUTORY INFORMATION

| Impact Laboratories Limited is a private company, limited by shares, domiciled in Scotland, registration number SC230837. The registered office is Impact Technology Centre, Fraser Road, Kirkton Campus, Livingston, EH54 7BU.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover represents net invoiced sales of goods and services in respect of technical consulting, testing and outsourcing business, excluding value added tax. Sales are recognised at the point which the service is complete.

| Tangible fixed assets and depreciation

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

| Land and buildings | - | 2% on cost

| Plant and machinery etc | - | 25% on cost and 10% on cost

| Tangible fixed assets are stated at cost less depreciation. Cost represent purchase price together with any incidental costs of acquisition.

| The directors have considered the residual value of all tangible fixed assets to be immaterial and therefore all tangible fixed assets are depreciated to nil value.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currency translation

| Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.

Impact Laboratories Limited (Registered number: SC230837)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

2. | ACCOUNTING POLICIES - continued

| Hire purchase and leasing commitments

| Assets held under finance leases, which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts, are capitalised in the balance sheet at their fair value and are depreciated over their useful lives. The capital elements of future obligations under the leases and hire purchase contracts are included as liabilities in the balance sheet.

| The interest elements of the rental obligations are charged in the profit and loss account over the periods of the leases and hire purchase contracts and represent a constant proportion of the balance of capital repayments outstanding.

| Rentals payable under operating leases are charged in the profit and loss account on a straight line basis over the lease term.

| Pensions

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Government grants

| Grants are credited to deferred revenue. Grants towards capital expenditure are released to the profit and loss account over the expected useful life of the assets. Grants towards revenue expenditure are released to the profit and loss account as the related expenditure is incurred.

| Financial instruments

| Financial instruments are classified and accounted for according to the substance of the contractual arrangement as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

| Provisions

| Provisions are recognised when the company has a legal or constructive obligation as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation, and the amount has been reliably estimated. Provisions are not recognised for future operating losses. Provisions are discounted where the time value of money is material.

| Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is

| determined by considering the class of obligations as a whole. A provision is recognised even if the likelihood of an outflow with respect to any one item included in the same class of obligations may be small.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 30 (2024 - 37 ) .

Impact Laboratories Limited (Registered number: SC230837)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

4. | TANGIBLE FIXED ASSETS

| Plant and |

| Land and |  | machinery |

| buildings |  | etc |  | Totals

£ | £ | £ |

| COST

| At 1 January 2025 | 3,368,088 |  | 2,122,748 |  | 5,490,836 |  |

| Additions | 18,267 |  | 77,041 |  | 95,308 |  |

| Disposals | - |  | (295 | ) | (295 | ) |

| At 31 December 2025 | 3,386,355 |  | 2,199,494 |  | 5,585,849 |  |

| DEPRECIATION

| At 1 January 2025 | 127,595 |  | 1,239,394 |  | 1,366,989 |  |

| Charge for year | 67,727 |  | 282,082 |  | 349,809 |  |

| Eliminated on disposal | - |  | (295 | ) | (295 | ) |

| At 31 December 2025 | 195,322 |  | 1,521,181 |  | 1,716,503 |  |

| NET BOOK VALUE

| At 31 December 2025 | 3,191,033 |  | 678,313 |  | 3,869,346 |  |

| At 31 December 2024 | 3,240,493 |  | 883,354 |  | 4,123,847 |  |

| Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

| Plant and |

| Land and |  | machinery |

| buildings |  | etc |  | Totals

£ | £ | £ |

| COST

| At 1 January 2025 | 185,955 |  | 854,305 |  | 1,040,260 |  |

| Additions | - |  | 68,250 |  | 68,250 |  |

| Disposals | - |  | (295 | ) | (295 | ) |

| At 31 December 2025 | 185,955 |  | 922,260 |  | 1,108,215 |  |

| DEPRECIATION

| At 1 January 2025 | 310 |  | 266,474 |  | 266,784 |  |

| Charge for year | 3,719 |  | 154,358 |  | 158,077 |  |

| Eliminated on disposal | - |  | (295 | ) | (295 | ) |

| At 31 December 2025 | 4,029 |  | 420,537 |  | 424,566 |  |

| NET BOOK VALUE

| At 31 December 2025 | 181,926 |  | 501,723 |  | 683,649 |  |

| At 31 December 2024 | 185,645 |  | 587,831 |  | 773,476 |  |

Impact Laboratories Limited (Registered number: SC230837)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

5. | FIXED ASSET INVESTMENTS

| Other

| investments

£ |

| COST

| At 1 January 2025

| and 31 December 2025 | 108,833 |  |

| NET BOOK VALUE

| At 31 December 2025 | 108,833 |  |

| At 31 December 2024 | 108,833 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Trade debtors | 276,777 |  | 279,389 |  |

| Amounts owed by related parties | 240,315 |  | 485,968 |  |

| Other debtors | 388,325 |  | 413,387 |  |

905,417 |  | 1,178,744 |  |

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Bank loans and overdrafts | 144,747 |  | 204,563 |  |

| Hire purchase contracts | 166,742 |  | 186,626 |  |

| Trade creditors | 62,135 |  | 21,061 |  |

| Taxation and social security | 58,754 |  | 69,482 |  |

| Other creditors | 24,931 |  | 160,147 |  |

457,309 |  | 641,879 |  |

8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Bank loans | 918,112 |  | 1,078,732 |  |

| Hire purchase contracts | 349,331 |  | 463,285 |  |

1,267,443 |  | 1,542,017 |  |

| Amounts falling due in more than five years:

| Repayable by instalments

| Bank loans more 5 yr by instal | 624,071 |  | 718,477 |  |

Impact Laboratories Limited (Registered number: SC230837)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

9. | SECURED DEBTS

| The following secured debts are included within creditors:

| 31.12.25 |  | 31.12.24

£ | £ |

| Hire purchase contracts | 516,073 |  | 649,911 |  |

| Bank loans | 921,337 |  | 980,790 |  |

1,437,410 |  | 1,630,701 |  |

| Hire purchase contracts are secured on the assets to which they relate.

| In respect of the loan provided by Bank of Scotland, there is a standard security held over the freehold property and a floating charge over all other assets held by the company.

10. | RELATED PARTY DISCLOSURES

| At the year end, the company was due £240,315 from companies under common control (2024:£485,968)